Table 4.
Variable | Odds Ratio | 95% Confidence Interval | P-value |
---|---|---|---|
Community strain type* | 1.32 | 0.68-2.59 | 0.41 |
Female Gender | 2.34 | 1.25-4.35 | 0.008 |
Age | 1.03 | 1.01-1.05 | 0.006 |
Type of infection | |||
Skin/soft tissue | Ref. | ||
Blood | 4.00 | 1.42-11.02 | 0.009 |
Pneumonia | 5.24 | 1.96-14.01 | 0.001 |
Other** | 3.33 | 0.93-11.93 | 0.064 |
Never treated with an anti-MRSA antibiotic | 9.46 | 1.71-52.21 | 0.01 |
Charlson Comorbidity Score*** | 1.15 | 1.02-1.29 | 0.02 |
APACHE II Score*** | 1.05 | 1.02-1.09 | 0.002 |
Ref.: reference group
Based on antibiotic susceptibility phenotype (MIC susceptible to gentamicin, clindamycin, and TMP-SMX)
Other infection type (n=46) includes 21 urinary tract infections, 19 intra-abdominal infections, 6 arterial or venous cardiovascular system infections.
These items measured each as continuous variables where odds ratio reflects changes for a one point change in the score.